Supraclavicular nerve block in addicts

Effect of adding sufentanil to marcaine solution 0.5% on the onset and duration of supraclavicular nerve block in addict and non addict patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201209165140N5

Enrollment

120

Registered

2014-03-11

Start date

2014-04-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regional anesthesia. ????? ?? ? ????? ?????? ???? ????? ???? ? ????? ?????? ? ????????

Interventions

Intervention 1: Patients in group 1 are administered the mentioned solution below in a single shot in the supraclavicular nerve block for upper limb regional anesthesia. Group 1, no history of opium

(intervention). Intervention 3: Patients in group 3 are administered the mentioned solution below in a single shot in the supraclavicular nerve block for upper limb regional anesthesia. Group 3, Pos

(intervention). Intervention 4: Patients in group 4 are administered the mentioned solution below in a single shot in the supraclavicular nerve block for upper limb regional anesthesia. Group 4, pos

Treatment - Drugs

Patients in group 1 are administered the mentioned solution below in a single shot in the supraclavicular nerve block for upper limb regional anesthesia. Group 1, no history of opium addiction,recei

Patients in group 2 are administered the mentioned solution below in a single shot in the supraclavicular nerve block for upper limb regional anesthesia. Group 2, No history of opium addiction who r

(intervention)

Patients in group 3 are administered the mentioned solution below in a single shot in the supraclavicular nerve block for upper limb regional anesthesia. Group 3, Positive history of opium addictio

Patients in group 4 are administered the mentioned solution below in a single shot in the supraclavicular nerve block for upper limb regional anesthesia. Group 4, positive history of opium addictio

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: A body mass index (BMI) less than 30 kilograms per cubic meter;American Society of anesthesiologists physical status class I and II;Elective forearm and arm surgery less than 180 minutes Exclusion criteria: Study protocol drug allergy ;Hepatic or renal disease ;An addiction to benzodiazepines or other non opioid substances;Pregnant women ;History of chronic pain

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Nerve block Duration. Timepoint: every 15 minutes. Method of measurement: pinprick test.	—

Secondary

Measure	Time frame
Onset of nerve block. Timepoint: every 5 minutes. Method of measurement: pinprick test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Omid Azimaraghi

Chief Resident of Anesthesiology , Dr Shariati Hospital

o.azimaraghi@gmail.com+98 21 2206 6194

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026